Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Journal of the Pediatric Infectious Diseases Society
|
October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19
Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
The AAPS Journal
|
September 4, 2024
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Darshana Jani, Michele Gunsior, Robin Marsden, et al.
The AAPS Journal
|
July 11, 2024
Neutralizing Antibody Sample Testing and Report Harmonization
Darshana Jani, Michele Gunsior, Robin Marsden, et al.
The Lancet. Infectious Diseases
|
September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial
Flonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
The New England Journal of Medicine
|
October 14, 2025
DB-OTO Gene Therapy for Inherited Deafness
Vassili Valayannopoulos, Manohar Bance, Daniela S Carvalho, et al.
The AAPS Journal
|
October 28, 2022
Anti-drug Antibody Sample Testing and Reporting Harmonization
Darshana Jani, Robin Marsden, Michele Gunsior, et al.
Bioanalysis
|
January 6, 2026
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (<u>PART 3A</u> - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance <u>PART 3B</u> - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
Omar Tounekti, Sophie Shubow, Sarah Wassmer, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Journal of the Pediatric Infectious Diseases Society
|
October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19
Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
The AAPS Journal
|
September 4, 2024
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Darshana Jani, Michele Gunsior, Robin Marsden, et al.
The AAPS Journal
|
July 11, 2024
Neutralizing Antibody Sample Testing and Report Harmonization
Darshana Jani, Michele Gunsior, Robin Marsden, et al.
The Lancet. Infectious Diseases
|
September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial
Flonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
The New England Journal of Medicine
|
October 14, 2025
DB-OTO Gene Therapy for Inherited Deafness
Vassili Valayannopoulos, Manohar Bance, Daniela S Carvalho, et al.
The AAPS Journal
|
October 28, 2022
Anti-drug Antibody Sample Testing and Reporting Harmonization
Darshana Jani, Robin Marsden, Michele Gunsior, et al.
Bioanalysis
|
January 6, 2026
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (<u>PART 3A</u> - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance <u>PART 3B</u> - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
Omar Tounekti, Sophie Shubow, Sarah Wassmer, et al.
Page
of 5